Stem Cell Therapy: Are we Ready to use it?
Jia-Ming Chang*, Yi-Chien Lin and Pei-Yi Tsai
Department of Pharmacology, Institute for Drug Evaluation Platform, Development Center for Biotechnology, Taiwan, Republic of China
- Corresponding Author:
- Jia-Ming Chang
Department of Pharmacology
Institute for Drug Evaluation Platform
Development Center for Biotechnology
New Taipei City, Taiwan
Republic of China
Email: [email protected]
Received date: February 25, 2014; Accepted date: April 5 2014; Published date: April 7, 2014
Citation: Chang JM, Lin YC and Tsai PY (2014) Stem Cell Therapy: Are we Ready to use it?. J Tissue Sci Eng 5:136. doi:10.4172/2157-7552.1000136
Copyright: © 2014 Chang JM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
The regenerative medicine is a fast growing innovation of health care for replacement of damaged or dysfunctional human organs or tissues with functional normal. However, the shortage of graft donors is the major concern of this treatment. To solve this problem, pluripotent or multipotent stem cells, which have the potential to differentiate into multiple lineages, provide an unlimited source of desired cells for transplantation. Even though stem cell therapy became a promising tool for regenerative medicine, unfortunately some unexpected adverse effects occurred in such treatments. Especially the incidence of life-threatening event from malignant teratomas, which are generated from undifferentiated stem cells in graft, is greater than that from damaged organs or tissues per se. Here, in this article the safety issues associated with stem cell therapy are reviewed, and in warnings for patients who want to receive this therapy are also mentioned.